When the Parkin gene is overexpressed, the migration and invasion ability of cancer cells is weakened, indicating that Parkin has the potential to inhibit pancreatic cancer, and its expression level is positively correlated. The gene discussed is PRKN; the disease is familial pancreatic carcinoma.